|
US2018148471A1
|
|
Methods for onapristone synthesis dehydration and deprotection
|
|
US2017266204A1
|
|
Onapristone metabolite compositions and methods
|
|
KR20170105113A
|
|
Compositions and methods for inhibiting viral infection
|
|
MX2017009119A
|
|
Compositions and methods for inhibiting fungal infections.
|
|
CN106999501A
|
|
Onapristone extended-release composition and method
|
|
WO2016064900A1
|
|
Methods and systems for camptothecin analog synthesis
|
|
WO2011143314A1
|
|
Compositions and methods for reducing proliferation and viability of lymphoblastoid cells
|
|
WO2011103563A1
|
|
Methods and compositions for inhibiting and preventing the growth of malignant mast cells
|
